[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339551-105":59,"doc-detail-339551-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tumor-microenvironment-responsive-nano-herb-and-crispr-delivery-system-for-synergistic-chemotherapy-and-immunotherapy","Tumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy","","Chemoresistance undermines effective breast cancer therapy and can drive recurrence. CRISPR-directed gene editing offers a way to reprogram the tumor microenvironment to reduce resistance, and Chinese herbal extracts have shown promise but suffer from limited tumor targeting and insufficient in vivo durability. A tumor microenvironment responsive nanoplatform is developed for nano-herb and CRISPR co-delivery to enhance long-term immunotherapy, combining isoliquiritigenin and doxorubicin with CRISPR editing of PTPN2.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-microenvironment-responsive-nano-herb-and-crispr-delivery-system-for-synergistic-chemotherapy-and-immunotherapy/339551/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-microenvironment-responsive-nano-herb-and-crispr-delivery-system-for-synergistic-chemotherapy-and-immunotherapy/339551.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is chemoresistance a problem in breast cancer treatment?","Question",{"text":113,"@type":114},"Chemoresistance makes it hard to achieve expected chemotherapy effects and can lead to cancer recurrence.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does CRISPR contribute in this study’s approach?",{"text":118,"@type":114},"CRISPR-directed gene editing targets PTPN2 to reprogram the tumor microenvironment and support long-term immunotherapy.",{"name":120,"@type":111,"acceptedAnswer":121},"What synergistic strategy is used to improve therapy?",{"text":122,"@type":114},"The work combines the nano-herb isoliquiritigenin with doxorubicin and enhances the effect through CRISPR-based PTPN2 gene editing.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339551,1790196249,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Jia et al. Journal of Nanobiotechnology (2024) 22:346  \n[https://doi.org/10.1186/s12951-024-02571-9](https://doi.org/10.1186/s12951-024-02571-9)  \nJournal of Nanobiotechnology  \n RESEARCH Open Access  \nTumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy  \nYuanyuan Jia1†, Yuhui Yao2†, Lingyao Fan2, Qiqing Huang1, Guohao Wei2, Peiliang Shen 1, Jia Sun1, Gaoshuang Zhu1, Zhaorui Sun3*, Chuandong Zhu2* and Xin Han 1*  \nAbstract  \nChemoresistance remains a significant challenge for effective breast cancer treatment which leads to cancer recurrence. CRISPR-directed gene editing becomes a powerful tool to reduce chemoresistance by reprogramming the tumor microenvironment. Previous research has revealed that Chinese herbal extracts have significant potential to overcome tumor chemoresistance. However, the therapeutic efficacy is often limited due to their poor tumor targeting and in vivo durability. Here we have developed a tumor microenvironment responsive nanoplatform  \n(H-MnO2(ISL + DOX)-PTPN2@HA, M(I + D)PH) for nano-herb and CRISPR codelivery to reduce chemoresistance. Synergistic tumor inhibitory effects were achieved by the treatment of isoliquiritigenin (ISL) with doxorubicin (DOX), which were enhanced by CRISPR-based gene editing to target protein tyrosine phosphatase non-receptor type 2 (PTPN2) to initiate long-term immunotherapy. Efficient PTPN2 depletion was observed after treatment with M(I + D) PH nanoparticles, which resulted in the recruitment of intratumoral infiltrating lymphocytes and an increase of proinflammatory cytokines in the tumor tissue. Overall, our nanoparticle platform provides a diverse technique for accomplishing synergistic chemotherapy and immunotherapy, which offers an effective treatment alternative for malignant neoplasms.  \nKeywords Doxorubicin (DOX), Isoliquiritigenin (ISL), CRISPR-Cas 9, Protein tyrosine phosphatase non-receptor type 2 (PTPN2), Immunotherapy, Synergistic therapy  \n†Yuanyuan Jia andYuhui Yao contribute equally to this work.  \n*Correspondence: Zhaorui Sun [sunzhr84@163.com](sunzhr84@163.com)[ ](sunzhr84@163.com)Chuandong Zhu [zhucd@njucm.edu.cn](zhucd@njucm.edu.cn)[ ](zhucd@njucm.edu.cn)Xin Han [xhan0220@njucm.edu.cn](xhan0220@njucm.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nJia et al. Journal of Nanobiotechnology (2024) 22:346 Page 2 of 16  \nGraphical Abstract  \nIntroduction  \nBreast cancer (BC) has become a major threat to women’s health worldwide, due to its early metastasis, with high recurrence rate and poor prognosis [1].At present, clinical treatme","cbCaivOOSZxbJrlQ","https://ap.wps.com/l/cbCaivOOSZxbJrlQ","pdf",3706581,16,"English","# Abstract\n## Introduction","[{\"question\":\"Why is chemoresistance a problem in breast cancer treatment?\",\"answer\":\"Chemoresistance makes it hard to achieve expected chemotherapy effects and can lead to cancer recurrence.\"},{\"question\":\"How does CRISPR contribute in this study’s approach?\",\"answer\":\"CRISPR-directed gene editing targets PTPN2 to reprogram the tumor microenvironment and support long-term immunotherapy.\"},{\"question\":\"What synergistic strategy is used to improve therapy?\",\"answer\":\"The work combines the nano-herb isoliquiritigenin with doxorubicin and enhances the effect through CRISPR-based PTPN2 gene editing.\"}]","Tumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy | PDF",1790030991,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/012197f00d395d49d0dcdd45333aa0ee.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a1e25ec82948da9969d4dd379a25628.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c8493d6394d78a7407b385fd71b19a0.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3bb3b3fec5026f366d7fb2cf75a426f.webp",980,1301]